UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus

Journal of theoretical biology, 2020-06, Vol.495, p.110254-110254, Article 110254

2020

Volltextzugriff (PDF)

Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study

Vaccine, 2023-01, Vol.41 (3), p.684-693

2023

Volltextzugriff (PDF)

Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo

BMC infectious diseases, 2022-10, Vol.22 (1), p.1-769, Article 769

2022

Volltextzugriff (PDF)

Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010

PloS one, 2016-03, Vol.11 (3), p.e0151575-e0151575

2016

Volltextzugriff (PDF)

Modeling the hepatitis A epidemiological transition in Thailand

Vaccine, 2016-01, Vol.34 (4), p.555-562

2016

Volltextzugriff (PDF)

Model-based projections of the population-level impact of hepatitis A vaccination in Mexico

Human vaccines & immunotherapeutics, 2012-08, Vol.8 (8), p.1099-1108

2012

Volltextzugriff (PDF)

Modeling the hepatitis A epidemiological transition in Brazil and Mexico

Human vaccines & immunotherapeutics, 2017-08, Vol.13 (8), p.1942-1951

2017

Volltextzugriff (PDF)

A Mathematical Model of Hepatitis A Transmission in the United States Indicates Value of Universal Childhood Immunization

Clinical infectious diseases, 2006-07, Vol.43 (2), p.158-164

2006

Volltextzugriff (PDF)

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models

PloS one, 2012-08, Vol.7 (8), p.e42320-e42320

2012

Volltextzugriff (PDF)

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium

Vaccines (Basel), 2023-05, Vol.11 (5), p.990

2023

Volltextzugriff (PDF)

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Vaccines (Basel), 2023-11, Vol.11 (11), p.1673

2023

Volltextzugriff (PDF)

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

npj vaccines, 2022-11, Vol.7 (1), p.156-156, Article 156

2022

Volltextzugriff (PDF)

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection

Human vaccines & immunotherapeutics, 2015-07, Vol.11 (7), p.1788-1802

2015

Volltextzugriff (PDF)

Potential future impact of a partially effective HIV vaccine in a southern African setting

PloS one, 2014-09, Vol.9 (9), p.e107214-e107214

2014

Volltextzugriff (PDF)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom

Human vaccines & immunotherapeutics, 2016-01, Vol.12 (1), p.8-19

2016

Volltextzugriff (PDF)

The role of simple mathematical models in malaria elimination strategy design

Malaria journal, 2009-09, Vol.8 (1), p.212-212, Article 212

2009

Volltextzugriff (PDF)

Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation

Journal of virology, 2019-09, Vol.93 (18), p.e00579-19

2019

Volltextzugriff (PDF)

A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?

BMC infectious diseases, 2014-05, Vol.14 (1), p.291-291, Article 291

2014

Volltextzugriff (PDF)

An Introduction to Maple V

1, 2001

Volltextzugriff (PDF)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach

Vaccine, 2017-01, Vol.35 (2), p.403-409

2017

Volltextzugriff (PDF)

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement

Human vaccines & immunotherapeutics, 2016-02, Vol.12 (2), p.451-466

2016

Volltextzugriff (PDF)

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

Human vaccines & immunotherapeutics, 2016-11, Vol.12 (11), p.2765-2771

2016

Volltextzugriff (PDF)

Response letter regarding the letter to the editors by Brown et al

Human vaccines & immunotherapeutics, 2016-07, Vol.12 (7), p.1943-1946

2016

Volltextzugriff (PDF)

Serotype replacement after pneumococcal vaccination

The Lancet (British edition), 2012-04, Vol.379 (9824), p.1387-1388

2012

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus

Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study

Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo

Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010

Modeling the hepatitis A epidemiological transition in Thailand

Model-based projections of the population-level impact of hepatitis A vaccination in Mexico

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

Modeling the hepatitis A epidemiological transition in Brazil and Mexico

A Mathematical Model of Hepatitis A Transmission in the United States Indicates Value of Universal Childhood Immunization

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection

Potential future impact of a partially effective HIV vaccine in a southern African setting

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom

The role of simple mathematical models in malaria elimination strategy design

Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation

A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?

An Introduction to Maple V

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

Response letter regarding the letter to the editors by Brown et al

Serotype replacement after pneumococcal vaccination

Suchergebnisse filtern